Product
Iron dextran
Aliases
Iron dextran 1000 mg IV
Name
INFED
INN Name
Iron Dextran
FDA Approved
Yes
4 clinical trials
3 organizations
9 indications
1 document
Indication
Iron Deficiency AnemiaIndication
Iron MalabsorptionIndication
AnaemiaIndication
Iron DeficiencyIndication
Complication of deliveryIndication
Acute Kidney InjuryIndication
AnemiaIndication
Iron-deficiency AnemiaIndication
MelanomaClinical trial
Intravenous Iron for Iron-deficiency Anemia in Pregnancy: a Randomized Controlled TrialStatus: Completed, Estimated PCD: 2019-12-31
Clinical trial
A Feasibility Trial of Intravenous Iron vs. Oral Iron Supplementation for the Treatment of Postpartum Anemia (IVIRONMAN)Status: Completed, Estimated PCD: 2023-03-15
Clinical trial
Effect of Intravenous Iron Repletion on Renal Function in Patients With Iron Deficiency and Acute Kidney Injury, Clinical TrialStatus: Active (not recruiting), Estimated PCD: 2023-09-30
Document
DailyMed Label: INFEDOrganization
General Injectables & Vaccines, Inc.Organization
Henry Schein, Inc.Organization
Allergan, Inc.Clinical trial
Pilot Trial Iron With Standard of Care Immunotherapy in MelanomaStatus: Not yet recruiting, Estimated PCD: 2026-06-01